202 related articles for article (PubMed ID: 37784196)
21. Transthyretin amyloidosis: Putting myopathy on the map.
Pinto MV; Milone M; Mauermann ML; Dyck PJB; Alhammad R; McPhail ED; Grogan M; Liewluck T
Muscle Nerve; 2020 Jan; 61(1):95-100. PubMed ID: 31587306
[TBL] [Abstract][Full Text] [Related]
22. Gait abnormalities in older adults with transthyretin cardiac amyloidosis.
Petros FE; Santos AM; Adeniyi A; Teruya S; De Los Santos J; Maurer MS; Agrawal SK
Amyloid; 2024 Jun; 31(2):116-123. PubMed ID: 38433466
[TBL] [Abstract][Full Text] [Related]
23. Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung Biopsy.
Ishida M; Enomoto M; Hata T; Tanaka T; Sakaguchi C; Tamiya N; Tsuchiya M; Nagasaka Y
Intern Med; 2022; 61(14):2203-2207. PubMed ID: 35850989
[TBL] [Abstract][Full Text] [Related]
24. Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.
Abouelhoda M; Mohty D; Alayary I; Meyer BF; Arold ST; Fadel BM; Monies D
Hum Genomics; 2021 Aug; 15(1):52. PubMed ID: 34380564
[TBL] [Abstract][Full Text] [Related]
25. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
26. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
[TBL] [Abstract][Full Text] [Related]
27. New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusing.
Hinderhofer K; Obermaier C; Hegenbart U; Schönland S; Seidler M; Sommer-Ort I; Barth U
Amyloid; 2019 Jun; 26(2):85-93. PubMed ID: 31074293
[TBL] [Abstract][Full Text] [Related]
28. Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy.
Ikeda K; Yamamoto D; Usui K; Takeuchi H; Oka N; Katoh N; Yazaki M; Kametani F; Nishino I; Hisahara S
Intern Med; 2023 Aug; 62(15):2261-2266. PubMed ID: 36543209
[TBL] [Abstract][Full Text] [Related]
29. A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.
Benbrahim M; Norman K; Sanchorawala V; Siddiqi OK; Hughes D
J Cardiovasc Pharmacol; 2021 May; 77(5):544-548. PubMed ID: 33657048
[TBL] [Abstract][Full Text] [Related]
30. Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis.
Chan GG; Koch CM; Connors LH
J Proteome Res; 2017 Apr; 16(4):1659-1668. PubMed ID: 28196416
[TBL] [Abstract][Full Text] [Related]
31. Ophthalmological involvement in wild-type transthyretin amyloidosis: A multimodal imaging study.
Frizziero L; Salvalaggio A; Cosmo E; Cipriani A; Midena E; Briani C
J Peripher Nerv Syst; 2023 Dec; 28(4):586-596. PubMed ID: 37552555
[TBL] [Abstract][Full Text] [Related]
32. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Gentile L; Diemberger I; Plante-Bordeneuve V; Mazzeo A; Dori A; Luigetti M; Di Paolantonio A; Dispenzieri A; Grogan M; Waddington Cruz M; Adams D; Inamo J; Kristen AV; Lino Cirami C; Chapman D; Gupta P; Glass O; Amass L
PLoS One; 2024; 19(1):e0292435. PubMed ID: 38241252
[TBL] [Abstract][Full Text] [Related]
34. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma.
Nelson LT; Paxman RJ; Xu J; Webb B; Powers ET; Kelly JW
Amyloid; 2021 Mar; 28(1):24-29. PubMed ID: 32811187
[TBL] [Abstract][Full Text] [Related]
35. Rare c.302C>T
Žebrauskienė D; Sadauskienė E; Masiulienė R; Aidietienė S; Šiaudinienė A; Pečeliūnas V; Žukauskaitė G; Žurauskas E; Valevičienė N; Barysienė J; Preikšaitienė E
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399526
[No Abstract] [Full Text] [Related]
36. Diffuse Alveolar Septal Amyloidosis With Wild-Type Transthyretin With Spontaneous Lung Hematoma.
Tomita E; Matsuo S; Tsukamoto Y; Fukuhara K; Akashi A
Ann Thorac Surg; 2019 Feb; 107(2):e131-e133. PubMed ID: 30009808
[TBL] [Abstract][Full Text] [Related]
37. A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report.
Thimm A; Oubari S; Hoffmann J; Carpinteiro A; Papathanasiou M; Luedike P; Kessler L; Rischpler C; Röcken C; Diebold I; Rassaf T; Schmidt H; Kleinschnitz C; Hagenacker T
BMC Neurol; 2022 Dec; 22(1):469. PubMed ID: 36494773
[TBL] [Abstract][Full Text] [Related]
38. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.
Nakagawa M; Sekijima Y; Yazaki M; Tojo K; Yoshinaga T; Doden T; Koyama J; Yanagisawa S; Ikeda S
Amyloid; 2016; 23(1):58-63. PubMed ID: 26852880
[TBL] [Abstract][Full Text] [Related]
39. Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease.
Fenoglio R; Baldovino S; Barreca A; Bottasso E; Sciascia S; Sbaiz L; Papotti M; Roccatello D
Nephron; 2022; 146(5):481-488. PubMed ID: 35307708
[TBL] [Abstract][Full Text] [Related]
40. Association between spinal stenosis and wild-type ATTR amyloidosis.
Godara A; Riesenburger RI; Zhang DX; Varga C; Fogaren T; Siddiqui NS; Yu A; Wang A; Mastroianni M; Dowd R; Nail TJ; McPhail ED; Kurtin PJ; Theis JD; Toskic D; Arkun K; Pilichowska M; Kryzanski J; Patel AR; Comenzo R
Amyloid; 2021 Dec; 28(4):226-233. PubMed ID: 34263670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
